CyclomicsSeq

At Cyclomics, we are pioneering advancements in molecular diagnostics with our flagship technology, CyclomicsSeq. This cutting-edge liquid biopsy and consensus sequencing platform enables highly sensitive detection of genetic mutations and cancer biomarkers from blood samples. Leveraging our deep expertise in molecular biology and sequencing, we have developed a suite of innovative technologies that offer robust solutions for plasmid sequencing, methylation analysis, and DNA barcoding.